A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Original Article CDKN2A/B rs4977756 and glioma risk: a meta-analysis
Int J Clin Exp Med
Several studies were performed to investigate the association between CDKN2A/B rs4977756 polymorphism and the risk of glioma. However, the results were inconsistent. Thus, we performed this meta-analysis. Methods: Eleven studies including 12814 glioma patients and 21140 controls were included in the meta-analysis. The pooled odds ratio (OR) and its corresponding 95% confidence interval (CI) was assessed. Results: CDKN2A/B rs4977756 polymorphism was significantly associated with an increasedfatcat:xfc6oto7ibfdzh46lythls66x4